Roberto Villa-Barriales
Ciber Cv
A Coruna, GA, Spain
A Coruna, GA, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 136 publications
Aficamten for Symptomatic Nonobstructive Hypertrophic Cardiomyopathy.
Journal: The New England journal of medicine
Published: August 28, 2026
Left Ventricular Hypertrabeculation and Prognosis in Dilated Cardiomyopathy.
Journal: Circulation
Published: August 03, 2026
Exercise Performance With Aficamten vs Metoprolol in Obstructive Hypertrophic Cardiomyopathy: The MAPLE-HCM Randomized Clinical Trial.
Journal: JAMA cardiology
Published: June 17, 2026
The Threshold for a Clinically Meaningful Improvement in Cardiopulmonary Exercise Testing Measures for Patients With Symptomatic Obstructive Hypertrophic Cardiomyopathy.
Journal: Journal of cardiac failure
Published: June 10, 2026
Efficacy of Aficamten vs Metoprolol According to Pretrial Beta-Blocker Treatment in Obstructive Hypertrophic Cardiomyopathy: Insights From MAPLE-HCM.
Journal: JACC. Heart failure
Published: June 08, 2026
Hypertrophic cardiomyopathy: a genome-wide association meta-analysis and polygenic risk score.
Journal: Journal of medical genetics
Published: May 13, 2026
Efficacy of Aficamten in Hypertrophic Cardiomyopathy Patients With Very-High Left Ventricular Outflow Tract Gradients.
Journal: The American journal of cardiology
Published: February 26, 2026
Long-Term Impact of Aficamten on Patient-Reported Outcome Measures in Obstructive Hypertrophic Cardiomyopathy: Results From FOREST-HCM.
Journal: European journal of heart failure
Published: February 18, 2026
Tracing the pathogenic PLN p.(Arg14del) variant across the globe; more than just a local curiosity.
Journal: Journal of cardiovascular translational research
Published: January 23, 2026
Last Updated: 09/26/2026